11 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Influenza A and B virus ... Varicella-zoster virus ... • Hepatitis A virus ... • Hepatitis B virus ... #IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Influenza A and B virus ... Varicella-zoster virus ... • Hepatitis A virus ... • Hepatitis B virus ... #IDSA #management
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... Antivirals #table #treatment ... #medications #infectiousdisease ... HepC #HepatitisC #Management ... #Pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
SARS-CoV-2, the virus ... Pandemic #Outbreak #InfectiousDiseases ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... COVID 19 - Zika virus ... Treatment: • Plasmapheresis ... #Syndrome #diagnosis ... #management #treatment
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... virus, human immunodeficiency ... virus (HIV), and ... Zika virus • Other ... #management #neurology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Herpes Simplex Virus ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
immunodeficiency virus ... CMV) • Epstein-Barr ... virus (EBV) • ... aplastic anemia Treatment ... hematology #diagnosis #management
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Varicella Zoster Virus ... because of vaccine virus ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology